{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T00:39:25Z","timestamp":1794530365286,"version":"4.9.1"},"reference-count":410,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.gastrohep.2024.502208","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T13:08:56Z","timestamp":1727701736000},"page":"502208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hipertensi\u00f3n portal: recomendaciones de diagn\u00f3stico y tratamiento. Documento de consenso de la Asociaci\u00f3n Espa\u00f1ola para el Estudio del H\u00edgado (AEEH) y el Centro para la Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd)"],"prefix":"10.1016","volume":"48","author":[{"given":"Agust\u00edn","family":"Albillos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Ba\u00f1ares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Hern\u00e1ndez-Gea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edilmar","family":"Alvarado-Tapias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Ampuero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Baiges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Bellot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"C\u00e1rdena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Vega","family":"Catalina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c0ngels","family":"Escorsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Garc\u00eda-Pagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Genesc\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Hern\u00e1ndez-Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Ib\u00e1\u00f1ez-Samaniego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabela","family":"Lens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elba","family":"Llop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena","family":"Simon-Talero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Mart\u00edn-Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Pose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Puente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Reverter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Rinc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Rodr\u00edguez-Gand\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"T\u00e9llez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Tur\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e1ndido","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2024.502208_bib1000","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.jhep.2015.01.003","article-title":"Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments","volume":"62","author":"Bosch","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cld.2021.01.002","article-title":"The Role of Hepatic Venous Pressure Gradient in the Management of Cirrhosis","volume":"25","author":"Veldhuijzen van Zanten","year":"2021","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1010","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.20062","article-title":"The hepatic venous pressure gradient: Anything worth doing should be done right","volume":"39","author":"Groszmann","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1015","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1365-2036.2010.04484.x","article-title":"Comparison of balloon vs. straight catheter for the measurement of portal hypertension","volume":"32","author":"Zipprich","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1020","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jvir.2016.03.048","article-title":"Calculating Hepatic Venous Pressure Gradient: Feel Free to Stay Free","volume":"27","author":"Bosch","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1025","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/hep.28031","article-title":"The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique","volume":"62","author":"Silva-Junior","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/liv.12229","article-title":"Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis","volume":"34","author":"Reverter","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1035","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/liv.13065","article-title":"The interpretation of hepatic venous pressure gradient tracings - excellent interobserver agreement unrelated to experience","volume":"36","author":"Tandon","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1040","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1002\/hep.32033","article-title":"Test-Retest Reliability and Consistency of HVPG and Impact on Trial Design: A Study in 289 Patients from 20 Randomized Controlled Trials","volume":"74","author":"Bai","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/hep.1840050312","article-title":"Presinusoidal portal hypertension in non-alcoholic cirrhosis","volume":"5","author":"Pomier-Layrargues","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1050","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.510300628","article-title":"Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis","volume":"30","author":"Perello","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1055","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2020.10.003","article-title":"Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis","volume":"74","author":"Ferrusquia-Acosta","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1060","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2008.07.019","article-title":"Portal hypertension and primary biliary cirrhosis: Effect of long-term ursodeoxycholic acid treatment","volume":"135","author":"Huet","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0168-8278(87)80035-1","article-title":"Portal hypertension in primary biliary cirrhosis Relationship with histological features","volume":"5","author":"Navasa","year":"1987","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1070","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/hep4.1154","article-title":"Liver stiffness measurement predicted liver-related events and all-cause mortality: A systematic review and nonlinear dose-response meta-analysis","volume":"2","author":"Wang","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1075","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s12072-019-09952-5","article-title":"The prognostic role of liver stiffness in patients with chronic liver disease: A systematic review and dose-response meta-analysis","volume":"13","author":"Shen","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1080","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1136\/gutjnl-2018-317334","article-title":"Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease","volume":"68","author":"Wong","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1085","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2020.11.050","article-title":"Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease","volume":"74","author":"Papatheodoridi","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1090","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jhep.2021.05.037","article-title":"Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease","volume":"75","author":"Rasmussen","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1095","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jhep.2021.06.003","article-title":"Baveno VI elastography criteria for ruling in cACLD works well in patients with MAFLD","volume":"75","author":"Ji","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1100","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/liv.15323","article-title":"Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology","volume":"42","author":"Calleja","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1105","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.22870","article-title":"Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography","volume":"49","author":"Masuzaki","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1110","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2893.2010.01355.x","article-title":"Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg-negative chronic hepatitis B","volume":"18","author":"Fung","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1115","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/hep.24121","article-title":"Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan)","volume":"53","author":"Jung","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1120","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1053\/j.gastro.2011.02.058","article-title":"Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C","volume":"140","author":"Vergniol","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1125","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1111\/j.1365-2893.2011.01493.x","article-title":"Transient elastography for predicting clinical outcomes in patients with chronic liver disease","volume":"19","author":"Klibansky","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.25599","article-title":"Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis","volume":"56","author":"Corpechot","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1135","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/j.gastro.2013.12.030","article-title":"Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis","volume":"146","author":"Corpechot","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1140","doi-asserted-by":"crossref","first-page":"e95776","DOI":"10.1371\/journal.pone.0095776","article-title":"Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease","volume":"9","author":"Pang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/HMER.S164250","article-title":"Spontaneous bacterial peritonitis in patients with cirrhosis: Incidence, outcomes, and treatment strategies","volume":"11","author":"Marciano","year":"2019","journal-title":"Hepat Med"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1150","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/liv.14325","article-title":"Controlled attenuation parameter reflects steatosis in compensated advanced chronic liver disease","volume":"40","author":"Piccinni","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1155","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/apt.16487","article-title":"Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease","volume":"54","author":"Zhou","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1160","doi-asserted-by":"crossref","first-page":"723","DOI":"10.14309\/ajg.0000000000000994","article-title":"Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease","volume":"116","author":"Pons","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1165","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1170","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1175","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/hep.30664","article-title":"The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials","volume":"70","author":"Sanyal","year":"2019","journal-title":"Hepatology."},{"key":"10.1016\/j.gastrohep.2024.502208_bib1180","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2021.10.023","article-title":"Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease","volume":"20","author":"Bassegoda","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1185","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/hep.28824","article-title":"Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The \u201cAnticipate\u201d study","volume":"64","author":"Abraldes","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1190","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1007\/s10620-021-07277-8","article-title":"Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography","volume":"67","author":"Podrug","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1195","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.14309\/ajg.0000000000001887","article-title":"A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease","volume":"117","author":"Dajti","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1200","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2022.09.032","article-title":"The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension","volume":"21","author":"Jachs","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1205","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0016-5085(96)70070-7","article-title":"Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure","volume":"111","author":"Bruix","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1210","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/hep.510300629","article-title":"Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation","volume":"30","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1215","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hep.27431","article-title":"Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis","volume":"61","author":"Berzigotti","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1220","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): A randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1225","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1230","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1055\/a-1939-4887","article-title":"Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline","volume":"54","author":"Gralnek","year":"2022","journal-title":"Endoscopy"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1235","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2016.05.027","article-title":"Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension","volume":"65","author":"Mandorfer","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1240","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.07.016","article-title":"Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis","volume":"153","author":"Lens","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1245","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/hep.30885","article-title":"Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy","volume":"71","author":"Mandorfer","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1250","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jhep.2020.05.050","article-title":"Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension","volume":"73","author":"Lens","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1255","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2014.03.012","article-title":"Reversal, maintenance or progression: What happens to the liver after a virologic cure of hepatitis C?","volume":"107","author":"Lee","year":"2014","journal-title":"Antiviral Res"},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2024.502208_bib1260","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1002\/hep.1840360707","article-title":"Fibrosis and disease progression in hepatitis C","volume":"36","author":"Marcellin","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1265","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.gastro.2006.03.014","article-title":"Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: A meta-analysis of individual patient data","volume":"130","author":"Leandro","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1270","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jhep.2022.08.025","article-title":"Non-invasive tests for clinically significant portal hypertension after HCV cure","volume":"77","author":"Semmler","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1275","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1478-3231.2012.02830.x","article-title":"Prognostic indicators of survival in patients with compensated and decompensated cirrhosis","volume":"32","author":"Zipprich","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1280","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/ajg.2013.110","article-title":"Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: A nationwide, prospective, 3-year follow-up study in Italy","volume":"108","author":"Bruno","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1285","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/MCG.0000000000000529","article-title":"Subclinical Ascites Does Not Affect the Long-term Prognosis in Hepatitis B Virus-related Cirrhosis Patients Receiving Antivirals","volume":"50","author":"Yim","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1290","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jceh.2017.06.001","article-title":"Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India","volume":"8","author":"Shah","year":"2018","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1295","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.03.065","article-title":"Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis","volume":"19","author":"Tonon","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1300","first-page":"93","article-title":"Natural history of grade 1 ascites in patients with liver cirrhosis","volume":"34","author":"Theodorakopoulos","year":"2021","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1305","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages of cirrhosis: A 25-year inception cohort study of 494 patients","volume":"39","author":"D\u2019Amico","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1310","first-page":"329","article-title":"Natural history of compensated viral B and D cirrhosis","volume":"14","author":"Gheorghe","year":"2005","journal-title":"Rom J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1315","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.21176","article-title":"The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients","volume":"43","author":"Sangiovanni","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1320","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cgh.2006.10.016","article-title":"Effect of prolonged interferon therapy on the outcome of hepatitis C virus-related cirrhosis: A randomized trial","volume":"5","author":"Fartoux","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1325","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1177\/135965350701200605","article-title":"Natural history of compensated and decompensated HCV-related cirrhosis in HIV-infected patients: A prospective multicentre study","volume":"12","author":"Giron-Gonzalez","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1330","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/QAI.0b013e31814be887","article-title":"Natural history of compensated viral cirrhosis in a cohort of patients with HIV infection","volume":"46","author":"Bruno","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1335","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1086\/605676","article-title":"Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients","volume":"49","author":"Pineda","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1340","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1478-3231.2010.02255.x","article-title":"Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis","volume":"30","author":"Das","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1345","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/MCG.0b013e31825079f1","article-title":"The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B","volume":"46","author":"Chon","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1350","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2012.10.023","article-title":"The natural history of compensated HCV-related cirrhosis: A prospective long-term study","volume":"58","author":"Gomez","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1355","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1097\/QAD.0b013e32836381f3","article-title":"Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV\/hepatitis C. virus-coinfected patients","volume":"27","author":"Macias","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1360","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/cid\/cit537","article-title":"Risk of liver decompensation among HIV\/hepatitis C virus-coinfected individuals with advanced fibrosis: Implications for the timing of therapy","volume":"57","author":"Macias","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1365","first-page":"223","article-title":"Is spleen stiffness a predictor of clinical decompensation in cirrhotic patients?","volume":"23","author":"Radu","year":"2014","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1370","doi-asserted-by":"crossref","first-page":"397","DOI":"10.15403\/jgld.2014.1121.234.msy","article-title":"The metabolic syndrome is not correlated with the short-term risk of decompensation in patients with cirrhosis","volume":"23","author":"Procopet","year":"2014","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1375","first-page":"425","article-title":"Hematologic indices improve with eradication of HCV in patients with cirrhosis and predict decompensation","volume":"77","author":"Karagozian","year":"2014","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1380","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3109\/00365521.2015.1081275","article-title":"Impact of portal hemodynamics on Doppler ultrasonography for predicting decompensation and long-term outcomes in patients with cirrhosis","volume":"51","author":"Kondo","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1385","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/jgh.13917","article-title":"Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression","volume":"33","author":"Ampuero","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1390","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/liv.14842","article-title":"Isolated bacterial infection without decompensation has no impact on survival of compensated patients with cirrhosis","volume":"41","author":"Reichert","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1395","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jhep.2004.01.005","article-title":"Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients","volume":"40","author":"Planas","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1400","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2006.08.007","article-title":"Natural history of patients hospitalized for management of cirrhotic ascites","volume":"4","author":"Planas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1405","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.23500","article-title":"Clinical course of alcoholic liver cirrhosis: A Danish population-based cohort study","volume":"51","author":"Jepsen","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1410","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2011.10.016","article-title":"Renal failure and cirrhosis: A systematic review of mortality and prognosis","volume":"56","author":"Fede","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1415","doi-asserted-by":"crossref","first-page":"100513","DOI":"10.1016\/j.jhepr.2022.100513","article-title":"Risk of further decompensation\/mortality in patients with cirrhosis and ascites as the first single decompensation event","volume":"4","author":"Balcar","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1420","doi-asserted-by":"crossref","first-page":"833","DOI":"10.14309\/ajg.0000000000002018","article-title":"Assessing the Risk of Further Decompensation and Survival in Patients With Cirrhosis With Variceal Bleeding as Their First Decompensation Event","volume":"118","author":"Gupta","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1425","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/liv.15582","article-title":"Carvedilol, probably the beta-blocker of choice for everyone with cirrhosis and portal hypertension: But not so fast!","volume":"43","author":"Villanueva","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1430","first-page":"CD011510","article-title":"Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices","volume":"10","author":"Zacharias","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1435","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jhep.2022.05.021","article-title":"Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis","volume":"77","author":"Villanueva","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1440","first-page":"CD004544","article-title":"Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults","volume":"8","author":"Gluud","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1445","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1155\/2011\/346705","article-title":"Endoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: A meta-analysis","volume":"25","author":"Li","year":"2011","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1450","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/liv.12452","article-title":"Drugs plus ligation to prevent rebleeding in cirrhosis: An updated systematic review","volume":"34","author":"Puente","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1455","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/hep.29267","article-title":"Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis","volume":"66","author":"Albillos","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1460","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jhep.2014.06.015","article-title":"Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding","volume":"61","author":"Stanley","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1465","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2012.07244.x","article-title":"Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding","volume":"27","author":"Lo","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1470","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/apt.16901","article-title":"Carvedilol versus endoscopic band ligation for secondary prophylaxis of variceal bleeding-long-term follow-up of a randomised control trial","volume":"55","author":"Dunne","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1475","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12072-016-9765-y","article-title":"Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT","volume":"11","author":"Gupta","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1480","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2022.06.007","article-title":"Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis","volume":"21","author":"Jachs","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1485","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2019.05.050","article-title":"Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis With or Without Ascites: A Meta-Analysis","volume":"18","author":"Turco","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1490","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2020.03.048","article-title":"Short-term hemodynamic effects of beta-blockers influence survival of patients with decompensated cirrhosis","volume":"73","author":"Alvarado-Tapias","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1495","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jhep.2017.02.005","article-title":"Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites","volume":"67","author":"Sinha","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1500","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/apt.16189","article-title":"Carvedilol is associated with improved survival in patients with cirrhosis: A long-term follow-up study","volume":"53","author":"McDowell","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1505","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/liv.15166","article-title":"Non-selective beta-blockers in patients with ascites: The complex interplay among the liver, kidney and heart","volume":"42","author":"Tellez","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1510","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jhep.2020.05.011","article-title":"Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites","volume":"73","author":"Tellez","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1515","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.03.005","article-title":"Nonselective beta blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"146","author":"Mandorfer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1520","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/lt.24744","article-title":"Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates","volume":"23","author":"Kim","year":"2017","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1525","first-page":"1008","article-title":"Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices","volume":"52","author":"Scheiner","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1530","doi-asserted-by":"crossref","first-page":"e0255","DOI":"10.1097\/HC9.0000000000000255","article-title":"Nonselective beta-blockers may lead to stage 2 acute kidney injury and waitlist mortality in child class C cirrhosis","volume":"7","author":"Lai","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1535","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12876-019-1155-1","article-title":"Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation","volume":"20","author":"Ngwa","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1540","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serste","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1545","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2011.01.034","article-title":"Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: A cross-over study","volume":"55","author":"Serste","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1550","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/hep.28575","article-title":"Propranolol use beyond 6 months increases mortality in patients with Child-Pugh C cirrhosis and ascites","volume":"64","author":"Kalambokis","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1555","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jhep.2019.10.002","article-title":"Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation","volume":"72","author":"Giannelli","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1560","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/gutjnl-2013-306502","article-title":"Non-selective beta-blockers are associated with improved survival in patients with ascites listed for liver transplantation","volume":"64","author":"Leithead","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1565","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/liv.13119","article-title":"Effect of propranolol on survival in patients with decompensated cirrhosis: A nationwide study based Danish patient registers","volume":"36","author":"Bang","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1570","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/apt.15439","article-title":"Systemic arterial blood pressure determines the therapeutic window of non-selective beta blockers in decompensated cirrhosis","volume":"50","author":"Tergast","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1575","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2015.10.018","article-title":"Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure","volume":"64","author":"Mookerjee","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1580","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/tri.13008","article-title":"Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: A case-control study","volume":"30","author":"Aravinthan","year":"2017","journal-title":"Transpl Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1585","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2021.02.033","article-title":"A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement","volume":"75","author":"Pose","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1590","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jhep.2017.08.008","article-title":"Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation","volume":"67","author":"Pascasio","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1595","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1111\/liv.13878","article-title":"Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting","volume":"38","author":"Perricone","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1600","doi-asserted-by":"crossref","first-page":"101714","DOI":"10.1016\/j.clinre.2021.101714","article-title":"Delisting and clinical outcomes of liver transplant candidates after hepatitis C virus eradication: A long-term single-center experience","volume":"45","author":"Nabatchikova","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1605","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/apt.16658","article-title":"Determinants of re-compensation in patients with hepatitis B virus-related decompensated cirrhosis starting antiviral therapy","volume":"55","author":"Kim","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1610","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jhep.2022.07.037","article-title":"Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis","volume":"77","author":"Wang","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1615","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41575-023-00846-4","article-title":"Recompensation in cirrhosis: UInravelling the evolving natural history of nonalcoholic fatty liver disease","volume":"21","author":"Feng","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1620","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.510290619","article-title":"Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests","volume":"29","author":"Amodio","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1625","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/j.1572-0241.2000.02265.x","article-title":"The prognostic significance of subclinical hepatic encephalopathy","volume":"95","author":"Hartmann","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1630","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1007\/s10620-010-1249-7","article-title":"Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver","volume":"55","author":"Dhiman","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1635","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/ajg.2014.264","article-title":"Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization","volume":"109","author":"Patidar","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1640","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jceh.2012.07.001","article-title":"Inhibitory control test for the detection of minimal hepatic encephalopathy in patients with cirrhosis of liver","volume":"2","author":"Taneja","year":"2012","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1645","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/1751-2980.12248","article-title":"Prospective comparative study of inhibitory control test and psychometric hepatic encephalopathy score for diagnosis and prognosis of minimal hepatic encephalopathy in cirrhotic patients in the Indian subcontinent","volume":"16","author":"Gupta","year":"2015","journal-title":"J Dig Dis"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1650","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1053\/j.gastro.2015.07.067","article-title":"Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis","volume":"149","author":"Ampuero","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1655","doi-asserted-by":"crossref","first-page":"e0146076","DOI":"10.1371\/journal.pone.0146076","article-title":"Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy","volume":"11","author":"Thomsen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1660","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.3748\/wjg.v23.i34.6321","article-title":"Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients","volume":"23","author":"Wang","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1665","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.dld.2018.01.133","article-title":"Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis","volume":"50","author":"Barone","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1670","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/jgh.14635","article-title":"Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: A propensity score-matching analysis","volume":"34","author":"Hanai","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1675","doi-asserted-by":"crossref","first-page":"e00172","DOI":"10.14309\/ctg.0000000000000172","article-title":"Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies","volume":"11","author":"Labenz","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1680","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/gutjnl-2015-310275","article-title":"Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort)","volume":"66","author":"Nahon","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1685","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2021.04.022","article-title":"Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis","volume":"75","author":"Villanueva","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1690","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/ajg.2011.173","article-title":"Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding","volume":"106","author":"Augustin","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1695","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MCC.0000000000000700","article-title":"The gastrointestinal system in the critically ill cirrhotic patient","volume":"26","author":"Olson","year":"2020","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1700","doi-asserted-by":"crossref","DOI":"10.1177\/17562848221101712","article-title":"Management of varices and variceal hemorrhage in liver cirrhosis: A recent update","volume":"15","author":"Diaz-Soto","year":"2022","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1705","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.emc.2019.03.008","article-title":"Critically Ill Patients with End-Stage Liver Disease","volume":"37","author":"Crager","year":"2019","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1710","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/0016-5085(86)90390-2","article-title":"Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution","volume":"90","author":"Kravetz","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1715","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1211801","article-title":"Transfusion strategies for acute upper gastrointestinal bleeding","volume":"368","author":"Villanueva","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1720","first-page":"CD002907","article-title":"Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding","volume":"2010","author":"Chavez-Tapia","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1725","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2036.2011.04746.x","article-title":"Meta-analysis: Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - An updated Cochrane review","volume":"34","author":"Chavez-Tapia","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1730","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1053\/j.gastro.2006.07.010","article-title":"Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage","volume":"131","author":"Fernandez","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1735","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2014.11.019","article-title":"Risk of Bacterial Infection in Patients With Cirrhosis and Acute Variceal Hemorrhage Based on Child-Pugh Class, and Effects of Antibiotics","volume":"13","author":"Tandon","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1740","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/liv.14936","article-title":"Fresh frozen plasma transfusion in acute variceal haemorrhage: Results from a multicentre cohort study","volume":"41","author":"Mohanty","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1745","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2014.03.035","article-title":"Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: An individual patient based meta-analysis of two controlled trials","volume":"61","author":"Bendtsen","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1750","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/hep.27363","article-title":"Activated recombinant factor VIIa should not be used in patients with refractory variceal bleeding: It is mostly ineffective, is expensive, and may rarely cause serious adverse events","volume":"60","author":"Sozio","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1755","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)30848-5","article-title":"Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): An international randomised, double-blind, placebo-controlled trial","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1760","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/liv.14012","article-title":"Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites","volume":"39","author":"Dam","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1765","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.gastro.2016.09.007","article-title":"Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study","volume":"152","author":"Tsai","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1770","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/hep.30304","article-title":"Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis","volume":"70","author":"Nardelli","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1775","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1111\/liv.13862","article-title":"Dose-dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis","volume":"38","author":"Tergast","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1780","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/apt.16008","article-title":"Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: A population-based study","volume":"52","author":"Labenz","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1785","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jvir.2018.10.015","article-title":"Proton Pump Inhibitor Use Is Associated with an Increased Frequency of New or Worsening Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation","volume":"30","author":"Lewis","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1790","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2022.03.052","article-title":"The Association Between Proton Pump Inhibitor Exposure and Key Liver-Related Outcomes in Patients With Cirrhosis: A Veterans Affairs Cohort Study","volume":"163","author":"Mahmud","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1795","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/jgh.12341","article-title":"Predictors of in-hospital mortality after acute variceal bleeding in patients with hepatocellular carcinoma and concurrent main portal vein thrombosis","volume":"29","author":"Han","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1800","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/HEP.0000000000000291","article-title":"Portal hypertension and variceal bleeding in patients with liver cancer: Evidence gaps for prevention and management","volume":"79","author":"Allaire","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1805","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/jim-2016-000375","article-title":"Randomized pragmatic trial of nasogastric tube placement in patients with upper gastrointestinal tract bleeding","volume":"65","author":"Rockey","year":"2017","journal-title":"J Investig Med"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1810","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jhep.2012.07.038","article-title":"Delayed endoscopy increases re-bleeding and mortality in patients with hematemesis and active esophageal variceal bleeding: A cohort study","volume":"57","author":"Chen","year":"2012","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2024.502208_bib1815","doi-asserted-by":"crossref","first-page":"e868","DOI":"10.1097\/MEG.0000000000002282","article-title":"Outcomes of early versus delayed endoscopy in cirrhotic patients with acute variceal bleeding: A systematic review with meta-analysis","volume":"33","author":"Bai","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1820","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/sjmms.sjmms_95_17","article-title":"Prophylactic Endotracheal Intubation in Patients with Upper Gastrointestinal Bleeding Undergoing Endoscopy: A Systematic Review and Meta-analysis","volume":"5","author":"Alshamsi","year":"2017","journal-title":"Saudi J Med Med Sci"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1825","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jgh3.12195","article-title":"Prophylactic endotracheal intubation in critically ill patients with upper gastrointestinal bleed: A systematic review and meta-analysis","volume":"4","author":"Chaudhuri","year":"2020","journal-title":"JGH Open"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1830","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s10620-006-9616-0","article-title":"Risk of aspiration pneumonia in suspected variceal hemorrhage: The value of prophylactic endotracheal intubation prior to endoscopy","volume":"52","author":"Koch","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1835","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jhep.2021.03.026","article-title":"Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis","volume":"75","author":"Martinez","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1840","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(95)92708-5","article-title":"Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients","volume":"346","author":"Levacher","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1845","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(97)05099-X","article-title":"Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: The European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial","volume":"350","author":"Avgerinos","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1850","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1365-2036.2012.05088.x","article-title":"Meta-analysis: Vasoactive medications for the management of acute variceal bleeds","volume":"35","author":"Wells","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1855","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/hep.27006","article-title":"Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage","volume":"60","author":"Seo","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1860","doi-asserted-by":"crossref","first-page":"110","DOI":"10.15403\/jgld-3191","article-title":"Vasoactive Agents for the Management of Acute Variceal Bleeding: A Systematic Review and Meta-analysis","volume":"30","author":"Huaringa-Marcelo","year":"2021","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1865","doi-asserted-by":"crossref","first-page":"e12826","DOI":"10.1097\/MD.0000000000012826","article-title":"Is additional 5-day vasoactive drug therapy necessary for acute variceal bleeding after successful endoscopic hemostasis? A systematic review and meta-analysis","volume":"97","author":"Yan","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1870","doi-asserted-by":"crossref","DOI":"10.1177\/00368504211031711","article-title":"Short-course vasoconstrictors are adequate for esophageal variceal bleeding after endoscopic variceal ligation: A systematic review and meta-analysis","volume":"104","author":"Yeh","year":"2021","journal-title":"Sci Prog"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1875","first-page":"334","article-title":"Comparison of 12-Hour with 72-Hour Terlipressin Therapy for Bleeding Esophageal Varices","volume":"27","author":"Salim","year":"2017","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1880","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/MEG.0000000000000300","article-title":"Comparison of 2 days versus 5 days of octreotide infusion along with endoscopic therapy in preventing early rebleed from esophageal varices: A randomized clinical study","volume":"27","author":"Rengasamy","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1885","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-123-4-199508150-00007","article-title":"Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis","volume":"123","author":"Laine","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1890","doi-asserted-by":"crossref","first-page":"E1503","DOI":"10.1055\/a-0901-7146","article-title":"Efficacy of endoscopic treatments for acute esophageal variceal bleeding in cirrhotic patients: Systematic review and meta-analysis","volume":"7","author":"Onofrio","year":"2019","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1895","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/gast.1996.v110.pm8566601","article-title":"Randomized comparison of ligation versus ligation plus sclerotherapy in patients with bleeding esophageal varices","volume":"110","author":"Laine","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1900","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/hep.28360","article-title":"Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: A multicenter randomized, controlled trial","volume":"63","author":"Escorsell","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1905","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-0039-1678726","article-title":"Balloon Tamponade and Esophageal Stenting for Esophageal Variceal Bleeding in Cirrhosis: A Systematic Review and Meta-analysis","volume":"39","author":"Rodrigues","year":"2019","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1910","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/hep.1840160607","article-title":"Prevalence, classification and natural history of gastric varices: A long-term follow-up study in 568 portal hypertension patients","volume":"16","author":"Sarin","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1915","doi-asserted-by":"crossref","first-page":"806586","DOI":"10.1155\/2014\/806586","article-title":"Cyanoacrylate injection compared with band ligation for acute gastric variceal hemorrhage: A meta-analysis of randomized controlled trials and observational studies","volume":"2014","author":"Ye","year":"2014","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1920","first-page":"CD010180","article-title":"Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension","author":"Rios Castellanos","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1925","doi-asserted-by":"crossref","first-page":"e1725","DOI":"10.1097\/MD.0000000000001725","volume":"94","author":"Qiao","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1930","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5114\/ceh.2023.126077","article-title":"Comparison of efficacy and safety of endoscopic and radiological interventions for gastric varices: A systematic review and network meta-analysis","volume":"9","author":"Giri","year":"2023","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1935","first-page":"e38233","article-title":"Use of Balloon Occluded Retrograde Transvenous Obliteration (BRTO) for Treatment of Gastric Varices: A Narrative Review","volume":"15","author":"Khakwani","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1940","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MCG.0000000000001305","article-title":"Balloon-occluded Retrograde Transvenous Obliteration Versus Transjugular Intrahepatic Portosystemic Shunt for Gastric Varices: A Meta-Analysis","volume":"55","author":"Yu","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1945","doi-asserted-by":"crossref","first-page":"E1057","DOI":"10.1055\/s-0042-114979","article-title":"Efficacy of argon plasma coagulation in the management of portal hypertensive gastropathy","volume":"4","author":"Hanafy","year":"2016","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1950","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1159\/000502814","article-title":"The Efficacy of Argon Plasma Coagulation versus Carvedilol for Treatment of Portal Hypertensive Gastropathy","volume":"101","author":"El Shahawy","year":"2020","journal-title":"Digestion"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1955","doi-asserted-by":"crossref","first-page":"107474","DOI":"10.1016\/j.ijscr.2022.107474","article-title":"Gastric Antral Vascular Ectasia (GAVE) a case report, review of the literature and update of techniques","volume":"98","author":"Fortuna","year":"2022","journal-title":"Int J Surg Case Rep"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1960","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/2050640620975243","article-title":"Endoscopic band ligation compared to thermal therapy for gastric antral vascular ectasia: A systematic review and meta-analysis","volume":"9","author":"Chalhoub","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1965","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00270-021-02836-y","article-title":"Transjugular Intrahepatic Portosystemic Shunt Creation for Treatment of Gastric Varices: Systematic Literature Review and Meta-Analysis of Clinical Outcomes","volume":"44","author":"Alqadi","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1970","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvir.2020.10.009","article-title":"Combined Transjugular Intrahepatic Portosystemic Shunt Plus Variceal Obliteration versus Transjugular Intrahepatic Portosystemic Shunt Alone for the Management of Gastric Varices: Comparative Single-Center Clinical Outcomes","volume":"32","author":"Shah","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1975","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00330-018-5645-2","article-title":"Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone and combined with embolisation for the management of cardiofundal varices: A retrospective study","volume":"29","author":"Yu","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1980","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/hep.20339","article-title":"Improved survival after variceal bleeding in patients with cirrhosis over the past two decades","volume":"40","author":"Carbonell","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1985","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1007\/s12072-022-10372-1","article-title":"Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: A propensity score matched study from the APASL ACLF Research Consortium (AARC)","volume":"16","author":"Sharma","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1990","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jhep.2020.04.024","article-title":"Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS","volume":"73","author":"Trebicka","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib1995","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jhep.2020.06.010","article-title":"Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding","volume":"74","author":"Kumar","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2000","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jhep.2020.10.009","article-title":"Futility criteria for preemptive TIPS in patients with cirrhosis and variceal bleeding are still missing in most severe patients!","volume":"74","author":"Depaire","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2005","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/hep.31913","article-title":"Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding","volume":"74","author":"Walter","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2010","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gutjnl-2022-326975","article-title":"Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding","volume":"72","author":"Rudler","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2015","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0016-5085(98)70436-6","article-title":"Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings","volume":"114","author":"Casado","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2020","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.09.026","article-title":"Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: A Meta-analysis of Individual Patient Data","volume":"160","author":"Nicoara-Farcau","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2025","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1478-3231.2007.01522.x","article-title":"Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: Long-term results of a randomized multicentre study","volume":"27","author":"Bureau","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2030","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2017.05.006","article-title":"Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding","volume":"67","author":"Wang","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2035","doi-asserted-by":"crossref","first-page":"e000531","DOI":"10.1136\/bmjgast-2020-000531","volume":"7","author":"de Wit","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2040","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/M20-0202","article-title":"The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: A Randomized Controlled Trial","volume":"174","author":"Bureau","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2045","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s10620-018-5412-x","article-title":"Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS)","volume":"64","author":"Maimone","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2050","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jhep.2021.01.023","article-title":"Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival","volume":"74","author":"Bettinger","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2055","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/liv.15606","article-title":"Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode","volume":"43","author":"Villagrasa","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2060","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/apt.12803","article-title":"Systematic review with meta-analysis: The effects of rifaximin in hepatic encephalopathy","volume":"40","author":"Kimer","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2070","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jhep.2017.11.005","article-title":"Hepatic encephalopathy: Classification and treatment","volume":"68","author":"Bajaj","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2075","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/hep.1840070404","article-title":"Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: A double-blind, randomized clinical trial","volume":"7","author":"Uribe","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2080","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep.28598","article-title":"Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis","volume":"64","author":"Gluud","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2085","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/BF02282344","article-title":"Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors","volume":"41","author":"Riggio","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2090","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2004.12.028","article-title":"Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: A randomized controlled study","volume":"42","author":"Riggio","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2095","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/apt.14275","article-title":"Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy","volume":"46","author":"Kang","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2100","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/MCG.0b013e3182506dbb","article-title":"The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis","volume":"46","author":"Hanouneh","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12072-015-9688-z","article-title":"Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: A prospective randomized open-label comparative multicenter study","volume":"10","author":"Assem","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2110","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/MEG.0000000000000724","article-title":"Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis","volume":"28","author":"Elfert","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2115","first-page":"CD013125","article-title":"Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: A network meta-analysis","volume":"1","author":"Komolafe","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12072-020-10025-1","article-title":"Antibiotics for prophylaxis of spontaneous bacterial peritonitis: Systematic review & Bayesian network meta-analysis","volume":"14","author":"Soni","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2125","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep.27941","article-title":"The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial","volume":"63","author":"Piano","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2130","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.08.026","article-title":"Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis","volume":"155","author":"Moreau","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.1840080107","article-title":"Recurrence of spontaneous bacterial peritonitis in cirrhosis: Frequency and predictive factors","volume":"8","author":"Tito","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2140","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hep.1840120416","article-title":"Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial","volume":"12","author":"Gines","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2145","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jhep.2013.03.012","article-title":"Increased risk of cognitive impairment in cirrhotic patients with bacterial infections","volume":"59","author":"Merli","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2016.09.156","article-title":"Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure","volume":"15","author":"Huelin","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2160","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/ajg.2017.19","article-title":"Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity","volume":"112","author":"Dionigi","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2165","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/0016-5085(86)90185-X","article-title":"Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis","volume":"91","author":"Runyon","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2170","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/liv.12795","article-title":"Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites","volume":"35","author":"Schwabl","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2175","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jhep.2014.11.036","article-title":"Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: A multicenter prospective study","volume":"62","author":"Terg","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2180","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jhep.2015.03.040","article-title":"Low ascitic fluid protein does not indicate an increased risk for spontaneous bacterial peritonitis in current cohorts","volume":"63","author":"Bruns","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2185","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fernandez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2190","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2015.10.019","article-title":"Management of the critically ill patient with cirrhosis: A multidisciplinary perspective","volume":"64","author":"Nadim","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2195","first-page":"164","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2200","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jhep.2014.11.017","article-title":"Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial","volume":"62","author":"Thevenot","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2205","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2012.06.013","article-title":"Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study","volume":"57","author":"Guevara","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2210","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cgh.2019.07.055","article-title":"Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis","volume":"18","author":"Fernandez","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2215","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"Electronic address eee European Association for the Study of the L. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2220","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12325-020-01550-4","article-title":"Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis","volume":"38","author":"Wang","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2225","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2023.02.023","article-title":"Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis","volume":"79","author":"Guerrero","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2230","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41424-018-0043-2","article-title":"Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis","volume":"9","author":"Senzolo","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2235","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","article-title":"Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis","volume":"10","author":"Delgado","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2240","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MEG.0000000000001237","article-title":"A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis","volume":"31","author":"Rodriguez-Castro","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2245","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1478-3231.2012.02785.x","article-title":"Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis","volume":"32","author":"Senzolo","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2250","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41395-018-0421-0","article-title":"Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis","volume":"114","author":"Pettinari","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2255","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1148\/radiol.12112236","article-title":"Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis","volume":"265","author":"Luca","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2260","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/liv.12929","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: Outcomes and predictors in a prospective cohort study","volume":"36","author":"Qi","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2265","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1136\/gutjnl-2017-314634","article-title":"Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: A randomised controlled trial","volume":"67","author":"Lv","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2270","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/lt.22105","article-title":"Portal vein thrombosis and liver transplant survival benefit","volume":"16","author":"Englesbe","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2275","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/tri.13353","article-title":"Mortality in liver transplant recipients with portal vein thrombosis - An updated meta-analysis","volume":"31","author":"Zanetto","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2280","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2023.01.007","article-title":"Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis","volume":"78","author":"Fundora","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2285","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4254\/wjh.v7.i13.1797","article-title":"Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysis","volume":"7","author":"Ditah","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2290","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/liv.14200","article-title":"Efficacy and safety of transjugular intrahepatic portosystemic shunt in difficult-to-manage hydrothorax in cirrhosis","volume":"39","author":"Jindal","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2295","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1007\/s10620-022-07522-8","article-title":"Refractory Hepatic Hydrothorax Is an Independent Predictor of Mortality When Compared to Refractory Ascites","volume":"67","author":"Osman","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2300","doi-asserted-by":"crossref","first-page":"904414","DOI":"10.3389\/fmed.2022.904414","article-title":"The impact and role of hepatic hydrothorax in the prognosis of patients with decompensated cirrhosis: A retrospective propensity score-matched study","volume":"9","author":"Ma","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2305","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MD.0000000000000025","article-title":"Hepatic hydrothorax: Clinical features, management, and outcomes in 77 patients and review of the literature","volume":"93","author":"Badillo","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2310","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1007\/s10620-020-06677-6","article-title":"Increased Risk of ACLF and Inpatient Mortality in Hospitalized Patients with Cirrhosis and Hepatic Hydrothorax","volume":"66","author":"O\u2019Leary","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2315","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/ajg.2013.219","article-title":"A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy","volume":"108","author":"Sharma","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2320","doi-asserted-by":"crossref","first-page":"e0267647","DOI":"10.1371\/journal.pone.0267647","article-title":"Combination therapy with rifaximin and lactulose in hepatic encephalopathy: A systematic review and meta-analysis","volume":"17","author":"Fu","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2325","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2019.08.047","article-title":"Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis","volume":"18","author":"Dhiman","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2330","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/hep.25507","article-title":"Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: A cost-effectiveness analysis","volume":"55","author":"Bajaj","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2335","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial","volume":"69","author":"Sola","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2340","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): An open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2345","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s12072-021-10247-x","article-title":"A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis","volume":"15","author":"Ng","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2350","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.31264","article-title":"Mortality and Hepatic Decompensation in Patients With Cirrhosis and Atrial Fibrillation Treated With Anticoagulation","volume":"73","author":"Serper","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2355","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s11239-021-02424-4","article-title":"Safety of direct oral anticoagulants in patients with mild to moderate cirrhosis: A systematic review and meta-analysis","volume":"52","author":"Nisly","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2360","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2023.04.028","article-title":"TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis","volume":"79","author":"Larrue","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2365","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/HEP.0000000000000613","article-title":"Pre-emptive TIPS in high-risk acute variceal bleeding An updated and revised individual patient data meta-analysis","volume":"79","author":"Nicoara-Farcau","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2370","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.dld.2016.10.011","article-title":"Consensus conference on TIPS management: Techniques, indications, contraindications","volume":"49","author":"Fagiuoli","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2375","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1097\/HEP.0000000000000283","article-title":"The impact of right atrial pressure on outcomes in patients undergoing TIPS, an ALTA group study","volume":"77","author":"Bommena","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2380","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/hep.29354","article-title":"Hospital volume and mortality after transjugular intrahepatic portosystemic shunt creation in the United States","volume":"67","author":"Sarwar","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2385","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.3748\/wjg.v26.i37.5561","article-title":"Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update","volume":"26","author":"Rajesh","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2390","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/hep.30934","article-title":"A Prospective Study Identifying Predictive Factors of Cardiac Decompensation After Transjugular Intrahepatic Portosystemic Shunt: The Toulouse Algorithm","volume":"70","author":"Billey","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2395","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jhep.2014.01.015","article-title":"Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: A randomized controlled trial","volume":"60","author":"Perarnau","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2400","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1111\/j.1572-0241.2005.00290.x","article-title":"Utility of color Doppler ultrasonography predicting tips dysfunction","volume":"100","author":"Abraldes","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2405","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.10.018","article-title":"A MELD-based model to determine risk of mortality among patients with acute variceal bleeding","volume":"146","author":"Reverter","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2410","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jhep.2007.10.008","article-title":"Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy","volume":"48","author":"Abraldes","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2415","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/jhep.2003.50385","article-title":"Upper digestive bleeding in cirrhosis Post-therapeutic outcome and prognostic indicators","volume":"38","author":"D\u2019Amico","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2420","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.cgh.2009.08.011","article-title":"Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis","volume":"7","author":"Augustin","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2425","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/hep.20386","article-title":"Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding","volume":"40","author":"Monescillo","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2430","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","article-title":"Early use of TIPS in patients with cirrhosis and variceal bleeding","volume":"362","author":"Garcia-Pagan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2435","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2012.08.020","article-title":"Use of early-TIPS for high-risk variceal bleeding: Results of a post-RCT surveillance study","volume":"58","author":"Garcia-Pagan","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2440","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/apt.12934","article-title":"Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival","volume":"40","author":"Rudler","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2445","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/hep.30182","article-title":"Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study","volume":"69","author":"Hernandez-Gea","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2450","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S2468-1253(19)30090-1","article-title":"Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: A randomised controlled trial","volume":"4","author":"Lv","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2455","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/apt.15797","article-title":"Randomised clinical trial: Standard of care versus early-transjugular intrahepatic porto-systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding","volume":"52","author":"Dunne","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2460","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/0016-5085(81)90144-X","article-title":"The course of patients after variceal hemorrhage","volume":"80","author":"Graham","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2465","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.1111\/tri.12090","article-title":"Salvage transjugular intrahepatic portosystemic shunt followed by early transplantation in patients with Child C14-15 cirrhosis and refractory variceal bleeding: A strategy improving survival","volume":"26","author":"Rudler","year":"2013","journal-title":"Transpl Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2470","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80065-1","article-title":"Transjugular intrahepatic portosystemic shunts: Comparison with paracentesis in patients with cirrhosis and refractory ascites: A randomized trial French Group of Clinicians and a Group of Biologists","volume":"25","author":"Lebrec","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2475","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","article-title":"A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites","volume":"342","author":"Rossle","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2480","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gines","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2485","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/gast.2003.50088","article-title":"The North American Study for the Treatment of Refractory Ascites","volume":"124","author":"Sanyal","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2490","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.20364","article-title":"Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites","volume":"40","author":"Salerno","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2495","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00535-010-0282-9","article-title":"Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: A prospective randomized trial","volume":"46","author":"Narahara","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2500","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","article-title":"Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites","volume":"152","author":"Bureau","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2505","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jhep.2010.08.025","article-title":"Serum bilirubin and platelet count: A simple predictive model for survival in patients with refractory ascites treated by TIPS","volume":"54","author":"Bureau","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2510","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: Meta-analysis of individual patient data","volume":"133","author":"Salerno","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2515","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/MEG.0000000000001890","article-title":"Long-term survival prediction for transjugular intrahepatic portosystemic shunt in severe cirrhotic ascites: Assessment of ten prognostic models","volume":"33","author":"Li","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2024.502208_bib2520","doi-asserted-by":"crossref","first-page":"e587","DOI":"10.1097\/MEG.0000000000002179","article-title":"A simple nomogram identifies patients with refractory ascites with worse outcome after transjugular intrahepatic portosystemic shunt","volume":"33","author":"Aicart-Ramos","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2525","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gutjnl-2011-301348","article-title":"The window hypothesis: Haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease","volume":"61","author":"Krag","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2530","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/hep.28352","article-title":"Nonselective beta-blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients","volume":"63","author":"Bossen","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2535","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2019.02.021","article-title":"Addition of Carvedilol to Gastric Variceal Obturation Does Not Decrease Recurrence of Gastric Variceal Bleeding in Patients With Cirrhosis","volume":"17","author":"Chen","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2540","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jhep.2011.12.021","article-title":"Efficacy of non-selective beta-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: A randomized controlled trial","volume":"56","author":"Hung","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2545","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1055\/s-2007-966591","article-title":"A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding","volume":"39","author":"Lo","year":"2007","journal-title":"Endoscopy"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2550","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1111\/j.1572-0241.2003.08769.x","article-title":"Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding","volume":"98","author":"Mahadeva","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2555","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.gie.2009.03.1169","article-title":"Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: A single-center U.S. analysis","volume":"70","author":"Procaccini","year":"2009","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2560","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1440-1746.2008.05651.x","article-title":"Treatment of patients with gastric variceal hemorrhage: Endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration","volume":"24","author":"Hong","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2565","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1872-034X.2011.00939.x","article-title":"Impact of balloon-occluded retrograde transvenous obliteration on management of isolated fundal gastric variceal bleeding","volume":"42","author":"Akahoshi","year":"2012","journal-title":"Hepatol Res"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2570","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2739\/kurumemedj.MS63009","article-title":"Balloon-occluded retrograde transvenous obliteration versus endoscopic injection sclerotherapy for isolated gastric varices: A comparative study","volume":"60","author":"Emori","year":"2014","journal-title":"Kurume Med J"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2575","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jvir.2018.12.008","article-title":"Balloon Retrograde Transvenous Obliteration Versus Endoscopic Cyanoacrylate in Bleeding Gastric Varices: Comparison of Rebleeding and Mortality with Extended Follow-up","volume":"30","author":"Stein","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2580","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/hep.31718","article-title":"Endoscopic Cyanoacrylate Injection Versus Balloon-Occluded Retrograde Transvenous Obliteration for Prevention of Gastric Variceal Bleeding: A Randomized Controlled Trial","volume":"74","author":"Luo","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2585","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/MCG.0000000000001275","article-title":"Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) Versus Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Treatment of Gastric Varices Because of Portal Hypertension: A Systematic Review and Meta-Analysis","volume":"54","author":"Paleti","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2590","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s12072-010-9206-2","article-title":"Rebleeding rates following TIPS for variceal hemorrhage in the Viatorr era: TIPS alone versus TIPS with variceal embolization","volume":"4","author":"Gaba","year":"2010","journal-title":"Hepatol Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2595","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1148\/radiol.13120800","article-title":"Recurrent variceal bleeding and shunt patency: Prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization","volume":"268","author":"Chen","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2600","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/hep.32453","article-title":"Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A randomized controlled trial","volume":"76","author":"Lv","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2605","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S2468-1253(22)00087-5","article-title":"Transjugular intrahepatic portosystemic shunt with or without gastro-oesophageal variceal embolisation for the prevention of variceal rebleeding: A randomised controlled trial","volume":"7","author":"Lv","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2610","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/apt.12824","article-title":"Review article: The management of portal hypertensive gastropathy and gastric antral vascular ectasia in cirrhosis","volume":"40","author":"Patwardhan","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2615","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jhep.2004.06.024","article-title":"Bleeding ectopic varices--treatment with transjugular intrahepatic porto-systemic shunt (TIPS) and embolisation","volume":"41","author":"Vangeli","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2620","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2036.2008.03719.x","article-title":"Bleeding ectopic varices in cirrhosis: The role of transjugular intrahepatic portosystemic stent shunts","volume":"28","author":"Kochar","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2625","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/apt.14947","article-title":"Variable efficacy of TIPSS in the management of ectopic variceal bleeding: A multicentre retrospective study","volume":"48","author":"Oey","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2630","first-page":"1104","article-title":"Recurrent bleeding from anorectal varices: Successful treatment with a transjugular intrahepatic portosystemic shunt","volume":"88","author":"Katz","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2635","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5604\/01.3001.0012.7934","article-title":"Case Series Regarding Parastomal Variceal Bleeding: Presentation and Management","volume":"18","author":"Romano","year":"2019","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2640","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S2468-1253(23)00209-1","article-title":"Diagnosis and management of ectopic varices in portal hypertension","volume":"8","author":"Tranah","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2645","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1053\/j.gastro.2007.01.040","article-title":"Risk factors for mortality after surgery in patients with cirrhosis","volume":"132","author":"Teh","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2650","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.31558","article-title":"Risk Prediction Models for Post-Operative Mortality in Patients With Cirrhosis","volume":"73","author":"Mahmud","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2655","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jamcollsurg.2008.09.006","article-title":"Nationwide volume and mortality after elective surgery in cirrhotic patients","volume":"208","author":"Csikesz","year":"2009","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2660","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2009.12.015","article-title":"Factors that predict outcome of abdominal operations in patients with advanced cirrhosis","volume":"8","author":"Telem","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2665","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bpg.2012.01.010","article-title":"Morbidity and mortality related to non-hepatic surgery in patients with liver cirrhosis: A systematic review","volume":"26","author":"de Goede","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2670","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjsurg.2018.12.008","article-title":"Outcomes in patients with portal hypertension undergoing gastrointestinal surgery: A propensity score matched analysis from the NSQIP dataset","volume":"217","author":"De Stefano","year":"2019","journal-title":"Am J Surg"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2675","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jhep.2019.07.007","article-title":"The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery","volume":"71","author":"Reverter","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2680","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1155\/2006\/245082","article-title":"Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: A retrospective, comparative study","volume":"20","author":"Vinet","year":"2006","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2685","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s11605-018-4053-x","article-title":"Original Study: Transjugular Intrahepatic Portosystemic Shunt as a Bridge to Abdominal Surgery in Cirrhotic Patients","volume":"23","author":"Tabchouri","year":"2019","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2690","doi-asserted-by":"crossref","first-page":"100442","DOI":"10.1016\/j.jhepr.2022.100442","article-title":"Preoperative TIPS prevents the development of postoperative acute-on-chronic liver failure in patients with high CLIF-C AD score","volume":"4","author":"Chang","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2695","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MCG.0b013e31818738ef","article-title":"Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery","volume":"43","author":"Kim","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2700","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2021.07.018","article-title":"North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension","volume":"20","author":"Boike","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2705","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1023\/A:1018819316633","article-title":"Risk factors and prevention of early infection after implantation or revision of transjugular intrahepatic portosystemic shunts: Results of a randomized study","volume":"43","author":"Deibert","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2710","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/jhep.2002.30418","article-title":"TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: A randomized controlled trial","volume":"35","author":"Escorsell","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2715","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1055\/s-2002-33565","article-title":"Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: A long-term randomized trial","volume":"34","author":"Sauer","year":"2002","journal-title":"Endoscopy"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2720","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1148\/radiol.15141252","article-title":"Advanced Cirrhosis Combined with Portal Vein Thrombosis: A Randomized Trial of TIPS versus Endoscopic Band Ligation Plus Propranolol for the Prevention of Recurrent Esophageal Variceal Bleeding","volume":"276","author":"Luo","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2725","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.05.011","article-title":"Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy","volume":"149","author":"Sauerbruch","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2730","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.28318","article-title":"Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy+beta-blocker for prevention of variceal rebleeding","volume":"63","author":"Holster","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2735","doi-asserted-by":"crossref","first-page":"e223201","DOI":"10.1148\/radiol.223201","article-title":"Small-Diameter Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Variceal Ligation Plus Propranolol for Variceal Rebleeding in Advanced Cirrhosis","volume":"308","author":"Wang","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2740","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.3748\/wjg.15.4781","article-title":"Portal hypertensive colopathy is associated with portal hypertension severity in cirrhotic patients","volume":"15","author":"Diaz-Sanchez","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2745","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cld.2019.07.004","article-title":"Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension: Review and Update of the Literature","volume":"23","author":"Hung","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2750","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMra2207738","article-title":"Primary Budd-Chiari Syndrome","volume":"388","author":"Garcia-Pagan","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2755","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jhep.2020.06.045","article-title":"Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis","volume":"74","author":"Magaz","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2760","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jhep.2019.01.009","article-title":"Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari syndrome","volume":"70","author":"Van Wettere","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2765","doi-asserted-by":"crossref","first-page":"100097","DOI":"10.1016\/j.jhepr.2020.100097","article-title":"Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome","volume":"2","author":"Van Wettere","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2770","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/SLA.0000000000001085","article-title":"Routine Preoperative Liver-specific Magnetic Resonance Imaging Does Not Exclude the Necessity of Contrast-enhanced Intraoperative Ultrasound in Hepatic Resection for Colorectal Liver Metastasis","volume":"262","author":"Arita","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2775","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/hep.26306","article-title":"Good long-term outcome of Budd-Chiari syndrome with a step-wise management","volume":"57","author":"Seijo","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2780","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"Electronic address eee EASL Clinical Practice Guidelines: Vascular diseases of the liver","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2785","article-title":"Diagnosis","volume":"15","author":"Intagliata","year":"2019","journal-title":"Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. Gastroenterology."},{"key":"10.1016\/j.gastrohep.2024.502208_bib2790","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular Liver Disorders Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2795","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.3748\/wjg.15.5028","article-title":"Interventional treatment for symptomatic acute-subacute portal and superior mesenteric vein thrombosis","volume":"15","author":"Liu","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2800","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1365-2036.2006.02820.x","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation","volume":"23","author":"Senzolo","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2805","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0043-121348","article-title":"Transjugular portal vein recanalization with creation of intrahepatic portosystemic shunt (PVR-TIPS) in patients with chronic non-cirrhotic, non-malignant portal vein thrombosis","volume":"56","author":"Klinger","year":"2018","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2810","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/apt.15044","article-title":"Systematic review with meta-analysis: Portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis","volume":"49","author":"Rodrigues","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2815","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1002\/hep.31915","article-title":"TIPS for Adults Without Cirrhosis With Chronic Mesenteric Venous Thrombosis and EHPVO Refractory to Standard-of-Care Therapy","volume":"74","author":"Knight","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2820","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/gast.2001.21209","article-title":"Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy","volume":"120","author":"Condat","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2825","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1160\/TH16-10-0781","article-title":"Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome","volume":"117","author":"Ageno","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2830","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/hep.28466","article-title":"Natural history and management of esophagogastric varices in chronic noncirrhotic, nontumoral portal vein thrombosis","volume":"63","author":"Noronha Ferreira","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2835","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2468-1253(19)30047-0","article-title":"Porto-sinusoidal vascular disease: Proposal and description of a novel entity","volume":"4","author":"De Gottardi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2840","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jhep.2022.05.033","article-title":"Porto-sinusoidal vascular disorder","volume":"77","author":"De Gottardi","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2845","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/hep.24422","article-title":"Idiopathic noncirrhotic portal hypertension","volume":"54","author":"Schouten","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2850","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/liv.12936","article-title":"Obliterative portal venopathy without portal hypertension: An underestimated condition","volume":"36","author":"Guido","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2855","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1016\/j.cgh.2020.11.039","article-title":"Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension","volume":"20","author":"Woran","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2860","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840110512","article-title":"Micronodular transformation (nodular regenerative hyperplasia) of the liver: A report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules","volume":"11","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2865","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2559.1988.tb02091.x","article-title":"Incomplete septal cirrhosis: Histopathological aspects","volume":"13","author":"Sciot","year":"1988","journal-title":"Histopathology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2870","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/01.pas.0000168508.70114.fd","article-title":"Abnormal intrahepatic portal vasculature in native and allograft liver biopsies: A comparative analysis","volume":"29","author":"Krasinskas","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2875","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jhep.2010.07.038","article-title":"Obliterative portal venopathy: Portal hypertension is not always present at diagnosis","volume":"54","author":"Cazals-Hatem","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2880","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00428-018-2355-8","article-title":"Pathology of idiopathic non-cirrhotic portal hypertension","volume":"473","author":"Guido","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2885","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1478-3231.2005.01151.x","article-title":"Study of portal vein thrombosis in patients with idiopathic portal hypertension in Japan","volume":"25","author":"Matsutani","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2890","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1365-2036.2012.05112.x","article-title":"Idiopathic noncirrhotic portal hypertension is associated with poor survival: Results of a long-term cohort study","volume":"35","author":"Schouten","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2895","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1002\/hep.26904","article-title":"Idiopathic portal hypertension: Natural history and long-term outcome","volume":"59","author":"Siramolpiwat","year":"2014","journal-title":"Hepatology."},{"key":"10.1016\/j.gastrohep.2024.502208_bib2900","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/gut.51.2.275","article-title":"Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: A re-evaluation in 28 patients","volume":"51","author":"Hillaire","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2905","doi-asserted-by":"crossref","first-page":"672458","DOI":"10.1155\/2014\/672458","article-title":"Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies","volume":"2014","author":"Pulvirenti","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2910","doi-asserted-by":"crossref","first-page":"e3081","DOI":"10.1097\/MD.0000000000003081","article-title":"Impact of Obliterative Portal Venopathy Associated With Human Immunodeficiency Virus","volume":"95","author":"Hollande","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2915","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MIB.0000000000001036","article-title":"Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy","volume":"23","author":"Seinen","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2920","first-page":"205","article-title":"Thrombophilic conditions in non-cirrhotic portal vein thrombosis","volume":"24","author":"Shah","year":"2005","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2925","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jhep.2015.11.027","article-title":"A de novo mutation in KCNN3 associated with autosomal dominant idiopathic non-cirrhotic portal hypertension","volume":"64","author":"Koot","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2930","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.28547","article-title":"Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension","volume":"64","author":"Bissonnette","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2935","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.cgh.2020.09.038","article-title":"The Clinical Spectrum and Diagnosis of Oxaliplatin Liver Injury in the Era of Nonalcoholic Fatty Liver Disease","volume":"19","author":"Kim","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2940","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/hep.32735","article-title":"Genetic predisposition to porto-sinusoidal vascular disorder: A functional genomic-based, multigenerational family study","volume":"77","author":"Shan","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2945","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/TP.0000000000004444","article-title":"Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome","volume":"107","author":"Magaz","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2950","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/jhep.2000.16597","article-title":"Recent portal or mesenteric venous thrombosis: Increased recognition and frequent recanalization on anticoagulant therapy","volume":"32","author":"Condat","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2955","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cgh.2008.07.031","article-title":"Portal hypertension-related complications after acute portal vein thrombosis: Impact of early anticoagulation","volume":"6","author":"Turnes","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2960","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.23259","article-title":"Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow-up study","volume":"51","author":"Plessier","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2965","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood.2020006827","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: A systematic review and meta-analysis","volume":"137","author":"Valeriani","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2970","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/jth.12121","article-title":"Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: Effect on new thrombotic events and gastrointestinal bleeding","volume":"11","author":"Spaander","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2975","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jhep.2022.08.023","article-title":"Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis","volume":"78","author":"Baiges","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2980","doi-asserted-by":"crossref","first-page":"18","DOI":"10.14309\/ajg.0000000000000486","article-title":"ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation","volume":"115","author":"Simonetto","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2985","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1182\/bloodadvances.2019001310","article-title":"The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis","volume":"4","author":"Naymagon","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2990","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ibd\/izaa053","article-title":"The Natural History Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel Disease","volume":"27","author":"Naymagon","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2024.502208_bib2995","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.surg.2020.11.016","article-title":"Characteristics, anticoagulation, and outcomes of portal vein thrombosis after intra-abdominal surgery","volume":"169","author":"Naymagon","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.gastrohep.2024.502208_bib3000","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/bloodadvances.2022007397","article-title":"Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: An interventional prospective cohort study","volume":"6","author":"Ageno","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.gastrohep.2024.502208_bib3005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.510310307","article-title":"Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors","volume":"31","author":"Denninger","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib3010","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/QAD.0b013e32832bfa51","article-title":"Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients","volume":"23","author":"Mallet","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.gastrohep.2024.502208_bib3015","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00277-020-03965-z","article-title":"Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis","volume":"99","author":"Alvarez-Larran","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib3020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jhep.2017.04.021","article-title":"Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study","volume":"67","author":"Poisson","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib3025","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ajh.26474","article-title":"Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complications","volume":"97","author":"Plessier","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.gastrohep.2024.502208_bib3030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/17474086.2021.1905512","article-title":"Heparin-induced thrombocytopenia: Pathophysiology, diagnosis and treatment","volume":"14","author":"Hvas","year":"2021","journal-title":"Expert Rev Hematol."},{"key":"10.1016\/j.gastrohep.2024.502208_bib3035","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: A meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.gastrohep.2024.502208_bib3040","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/hep.21354","article-title":"Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome","volume":"44","author":"Plessier","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2024.502208_bib3045","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/MEG.0000000000000632","article-title":"Increased prevalence of heparin-induced thrombocytopenia in patients with Budd-Chiari syndrome: A retrospective analysis","volume":"28","author":"Zaman","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570524001663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570524001663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:44:52Z","timestamp":1736037892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570524001663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":410,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0210570524001663"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2024.502208","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hipertensi\u00f3n portal: recomendaciones de diagn\u00f3stico y tratamiento. Documento de consenso de la Asociaci\u00f3n Espa\u00f1ola para el Estudio del H\u00edgado (AEEH) y el Centro para la Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd)","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2024.502208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Espa\u00f1a S.L.U. and AR\u00c1N EDICIONES, S.L. on behalf of Sociedad Espa\u00f1ola de Patolog\u00eda Digestiva.","name":"copyright","label":"Copyright"}],"article-number":"502208"}}